Cardiovascular risk assessment in women – an update
Cardiovascular disease is the leading cause of morbidity and mortality in postmenopausal women. Although it is a disease of aging, vascular disease initiates much earlier in life.
Thus, there is a need to be aware of the potential to prevent the development of the disease from an early age and continue this surveillance throughout life. The menopausal period and early menopause present an ideal opportunity to assess cardiovascular risk and plan accordingly. Generally in this period, women will be seen by primary health-care professionals and non-cardiovascular specialists.
This review addresses female specific risk factors that may contribute to the potential development of cardiovascular disease.
It is important for all health-care professionals dealing with women in midlife and beyond to be cognisant of these risk factors and to initiate female-specific preventative measures or to refer to a cardiovascular specialist.
A White Paper - Cardiovascular risk assessment in women - an update867.2 KB
Note: The IMS grants permission to individuals only to reproduce the copies of the review for their own personal use but requests that organisations contact Ms Lee Tomkins, IMS Executive Director for advice on how to order reprints at
Reference
P. Collins, C. M. Webb, T. J. de Villiers, J. C. Stevenson, N. Panay & R. J. Baber (2016) Cardiovascular risk assessment in women – an update, Climacteric, 19:4, 329-336, DOI: 10.1080/13697137.2016.1198574 http://dx.doi.org/10.1080/13697137.2016.1198574
Content updated 28 October 2016